Avigen Logo
About Avigen Research & Development Pipeline Clinical Trials Investors Contact Us
 

Avigen's AV513 technology was recently divested to Baxter Healthcare Corporation. Please refer to Avigen's Press Release dated December 18, 2008 for more information.

AV411 AV513